EGFR and metastatic malignant neoplasm in the lymph nodes: Remarkably, the exosomal levels of these proteins, including the EGFR, correlated with clinicopathological parameters, being higher in patients with stage III/IV disease and lymph node metastases versus those with stage I/II disease and without lymph node metastases (112).